Health Care: Drugs

Emergent BioSolutions Inc (EBS: NYSE)

$32.11 1.91 | 6.32%
05/26/17 - 04:02 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 488.78M 489.33M 404.47M 312.75M
Cost of Sales 93.06M 72.15M 69.51M 43.17M
Gross Operating Profit 395.73M 417.18M 334.96M 269.58M
Selling, General, and Administrative Expenses 143.69M 121.14M 108.59M 87.88M
Research & Development 108.29M 119.19M 104.72M 119.93M
Operating Income before D & A (EBITDA) 143.75M 176.85M 121.64M 61.76M
Depreciation & Amortization 38.23M 35.34M 32.45M 18.96M
Interest Income 1.05M 572.00K 320.00K 139.00K
Other Income - Net 263.00K 153.00K 2.93M 426.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 106.84M 142.24M 92.43M 43.37M
Interest Expense 7.62M 6.52M 8.24M 0.00
Pre-Tax Income 99.22M 135.72M 84.19M 43.37M
Income Taxes 36.70M 44.30M 29.93M 13.11M
Minority Interest 0.00 0.00 0.00 -876.00K
Net Income From Continuing Operations 62.52M 91.42M 54.27M 30.26M
Net Income From Discontinued Operations -10.75M -28.55M -17.52M 0.00
Net Income From Total Operations 51.78M 62.87M 36.74M 30.26M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 51.78M 62.87M 36.74M 31.14M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
62.52M 91.42M 54.27M 30.26M
Preferred Dividends
Net Income Available To Common 62.52M 91.42M 54.27M 30.26M
Basic EPS from Continuing Ops. 1.56 2.37 1.45 0.86
Basic EPS from Discontinued Ops. -0.27 -0.74 -0.47 0.00
Basic EPS from Total Operations 1.29 1.63 0.98 0.86
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.29 1.63 0.98 0.86
Basic Normalized Net Income/Share 1.56 2.37 1.45 0.86
EPS fr Continuing Ops. 1.35 2.02 1.26 0.85
EPS fr Discontinued Ops -0.22 -0.61 -0.38 0.00
EPS fr Total Ops. 1.13 1.41 0.88 0.85
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.13 1.41 0.88 0.85
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.35 2.02 1.26 0.85
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with EBS

Latest EBS Headlines from TheStreet

More Financial News for EBS

Press Releases for EBS

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter